CenExeli Research LLC
Savannah, Georgia 31405
7 studies enrolling now · 30 studies all time
What they study most
Agitation, Alzheimer Disease, Alzheimer's Disease, Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Bipolar Disorder, Bipolar Disorder Type I With Mania, Bipolar-I Disorder With Mania or Mania With Mixed Features, Brain Diseases, Cannabis Withdrawal, Central Nervous System Diseases, Contraception
Studies at this site
- Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder — Recruiting now
- Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients — Recruiting now
- A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder — Recruiting now
- A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine — Recruiting now
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease — Recruiting now
- Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD — Recruiting now
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — Running, not enrolling
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Running, not enrolling
- Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine — Running, not enrolling
- A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) — Running, not enrolling
- A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) — Running, not enrolling
- A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease — Completed
- A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM — Completed
- A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight — Running, not enrolling
- A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD — Completed
- A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia — Completed
- A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder — Completed
- Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients — Completed
- Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
- A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
- Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine — Completed
- Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression — Completed
- BHV-7000 Open-Label Extension Bipolar Mania Study — Stopped early
- BHV-7000 Acute Treatment of Bipolar Mania — Completed
- ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Completed
- A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus — Completed
- An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD — Completed
- A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
- Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles — Completed